MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland. Show more

9713 Key West Avenue, Rockville, MD, 20850, United States

Medical Devices
Healthcare
Start AI Chat

Market Cap

80.25M

52 Wk Range

$0.64 - $3.97

Previous Close

$0.75

Open

$0.77

Volume

1,083,172

Day Range

$0.74 - $0.80

Enterprise Value

63.58M

Cash

105.7M

Avg Qtr Burn

-7.458M

Insider Ownership

1.77%

Institutional Own.

75.89%

Qtr Updated

09/30/25


Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date